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Abstract
Background/aim: Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common multidrug-resistant
organisms in healthcare settings worldwide, but little is known about MRSA transmission outside of acute healthcare
settings especially in Asia. We describe the methods for a prospective longitudinal study of MRSA prevalence and
transmission.
Methods: MRSA-colonized individuals were identified from MRSA admission screening at two tertiary hospitals and
recruited together with their household contacts. Participants submitted self-collected nasal, axilla and groin (NAG)
swabs by mail for MRSA culture at baseline and monthly thereafter for 6 months. A comparison group of households
of MRSA-negative patients provided swab samples at one time point. In a validation sub-study, separate swabs from
each site were collected from randomly selected individuals, to compare MRSA detection rates between swab sites,
and between samples collected by participants versus those collected by trained research staff. Information on each
participant’s demographic information, medical status and medical history, past healthcare facilities usage and contacts,
and personal interactions with others were collected using a self-administered questionnaire.
Discussion/conclusion: Understanding the dynamics of MRSA persistence and transmission in the community is crucial
to devising and evaluating successful MRSA control strategies. Close contact with MRSA colonized patients may to be
important for MRSA persistence in the community; evidence from this study on the extent of community MRSA could
inform the development of household- or community-based interventions to reduce MRSA colonization of close contacts
and subsequent re-introduction of MRSA into healthcare settings. Analysis of longitudinal data using whole-genome
sequencing will yield further information regarding MRSA transmission within households, with significant implications for
MRSA infection control outside acute hospital settings.
Keywords: Cohort studies, Longitudinal studies, MRSA, Staphylococcus aureus, Methicillin, Antimicrobial resistance
epidemiology, Community, Colonization, Household transmission
* Correspondence: ephns@nus.edu.sg
1Saw Swee Hock School of Public Health, Tahir Foundation Building, 12
Science Drive 2, 11-01, Singapore 117549, Singapore
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Shankar et al. BMC Infectious Diseases  (2017) 17:678 
DOI 10.1186/s12879-017-2793-y
Background
Since its emergence in the 1960s, methicillin-resistant
Staphylococcus aureus (MRSA) has become one of the most
common multidrug-resistant organisms in healthcare set-
tings worldwide, resulting in considerable health and eco-
nomic burden. Carriage of MRSA is a major risk factor for
invasive MRSA infection [1–8], and patient transfers be-
tween acute care hospitals, community hospitals and long-
term care facilities have been reported to be important for
maintaining MRSA transmission in healthcare settings [9–
17]. MRSA transmission from MRSA-infected patients and
MRSA carriers to their household contacts has also been
documented [18–22], but the importance of household
transmission for persistence of MRSA in the community and
reintroduction into healthcare settings is not well under-
stood. A number of cross-sectional studies have suggested
that between 20% and 30% of household contacts of MRSA
positive index patients are colonized with MRSA [23, 24]. A
limited number of longitudinal studies have shown that
MRSA transmission to household contacts is common, with
20% - 40% of non-colonized household contacts of MRSA
positive individuals acquiring MRSA during the follow-up
period [18, 20–22]. Identified risk factors for MRSA acquisi-
tion among household contacts include older age [20] and
providing care to MRSA-colonized individuals [20, 25].
In Singapore, MRSA is endemic in healthcare facilities
[26, 27]. A laboratory-based program in six public sector
acute care hospitals (ACHs) reported that 35% of all clinical
S. aureus isolates were methicillin-resistant [26]. MRSA
Sequence Type (ST) 239 was predominant in Singaporean
hospitals in the mid-1980s, but was rapidly supplanted as
the major clone following the introduction of ST22 in the
early 2000s [28]. More recently, ST45 was introduced into
local hospitals. Community-associated (CA) MRSA strains
have also been identified sporadically since the early 2000s,
with ST30 being the predominant clonal strain [29].
Specific measures adopted by healthcare institutions to
control MRSA include active surveillance in tertiary care
hospitals, cohorting or isolation of MRSA colonized
patients and hand hygiene initiatives. Historical evalua-
tions of these bundled MRSA interventions at two major
tertiary care hospitals have documented a sustained
decrease in MRSA infection and hospital acquired bac-
teraemia rates of 50% - 60% between 2004 and 2012,
alongside significant increases in hand hygiene compli-
ance among healthcare workers [30]. Reducing
colonization is believed to be crucial to reducing MRSA
burden, as colonization is a major risk factor for subse-
quent infection, and infection carries a high risk of
excess morbidity and mortality [25, 26, 31, 32].
Despite these efforts to control MRSA transmission in
ACHs, intermediate-term and long-term care facilities
remain as important reservoirs [11]. A recent survey indi-
cated that MRSA colonization prevalence is substantially
higher among patients in intermediate-term (29.9%) and
long-term (20.4%) care facilities compared with acute care
hospitals (11.8%) [11]. Several studies have suggested a
role of long-term care facilities for sustaining MRSA en-
demicity in healthcare networks [11, 14, 16, 17, 33]. How-
ever, relatively little is known about the role of MRSA
transmission in the wider, non-hospitalized community in
maintaining MRSA transmission and reintroducing
MRSA strains into healthcare settings. A few longitudinal
studies have demonstrated the potential for MRSA trans-
mission from colonized patients to their household con-
tacts, suggesting the existence of a large reservoir of
MRSA in the general population. However, the relation-
ship between these community transmission events and
the epidemiology of MRSA in healthcare settings is not
well understood.
In recent years, whole genome sequencing (WGS) has
emerged as the leading technology for the study of bac-
terial population genetics and transmission dynamics
[34–37]. WGS has provided crucial insights into the epi-
demiology of antibiotic resistance, the genetics of viru-
lence, the origins and expansion of lineages, and the
population structure of S. aureus [38]. The high reso-
lution of WGS means that it offers superior data com-
pared with other molecular typing techniques to
determine transmission events, and profile resistance,
virulence and even the type isolates [38–40] within days
[41]. Various studies have used WGS to track MRSA
transmission networks in healthcare settings [9, 11, 12,
33, 42–44] and the community [44]. To our knowledge,
however, no study has investigated MRSA carriage and
transmission among households using WGS. We de-
scribe the methods for an ongoing longitudinal study to
investigate the persistence and transmissibility of MRSA
in the community, and to quantify the relationship be-
tween healthcare contact and community transmission.
Methods
The overall aim of this study is to determine the dynam-
ics of MRSA carriage, persistence and transmission in
the community. The specific objectives are:
a) To measure frequency of MRSA colonization among
household contacts
b) To identify risk factors associated with colonization
and prolonged carriage
c) To study MRSA transmission in household contacts
of MRSA-colonized patients (after discharge)
d) To identify factors associated with MRSA
persistence in the household
e) To quantify importance of healthcare contact, and
other personal interactions, in the transmission of
MRSA in the community
f ) To determine the diversity of MRSA strains
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This study will comprise a baseline survey of MRSA
prevalence and risk factors among household contacts of
100 MRSA-colonized and 100 MRSA non-colonized
index patients, followed by a 6-month longitudinal study
among MRSA-colonized index patients and their house-
hold contacts, with monthly self-swabbing and question-
naire interview.
Index patients will be recruited from two acute and
tertiary care hospitals in Singapore. Hospital 1 has 1600
beds and primarily serves an elderly population. Active
MRSA admission screening based on nasal swab poly-
merase chain reaction (PCR) has been conducted since
2009. Positive patients are cohorted in dedicated MRSA
wards. Hospital 2 is a university hospital with 1000 beds
serving a mixed population. Active MRSA admission
screening based on nose, axilla and groin swab culture
has been conducted since 2010. Positive patients are al-
located to dedicated MRSA cubicles within each ward.
Potential index patients for the MRSA-colonized and
MRSA non-colonized arms will be selected from daily
lists of patients undergoing MRSA screening on admis-
sion. Index patients will be eligible for inclusion in the
MRSA-colonized arm if:
1) They are aged 21 years or above
2) They have a positive MRSA screen at admission
3) They live in a household with at least one other person
who routinely spends nights at the same address
Patients will be excluded if they live in an institutional-
ized setting, such as a nursing home, or if they are ad-
mitted to an intensive care unit at the time of
recruitment. Eligibility and exclusion criteria for index
patients in the MRSA non-colonized arm will be the
same, with the exception that the patient must test nega-
tive for MRSA upon admission screening.
Eligible patients will be approached in the ward by
trained research staff to explain the study in the patients’
preferred language (English, Mandarin, Malay or Tamil)
and to invite them to participate in the study. Interested
patients will be asked to provide signed informed con-
sent and consent to contact their household for the pur-
poses of recruiting household members. For potential
participants suffering from cognitive impairment, in-
formed consent will be obtained from their legally
appointed representative, usually a spouse or family
member responsible for making healthcare decisions on
behalf of their patients.
Research staff will then arrange a house visit to recruit
household contacts of the index case. A household con-
tact will be defined as a person who routinely spends
nights at the same address as the index patient. House-
hold contacts interested in taking part will be asked to
provide signed informed consent. Parental consent and
participant assent will be obtained for participants aged
six to 20 years; children below six years will not be
eligible to participate. A baseline questionnaire will be
administered to each participating household member,
to collect information on each participant’s demographic
information, medical status and medical history, past
healthcare facilities usage and contacts, and personal in-
teractions with others. Participants will then be shown
the correct procedure for obtaining swabs from the
nares, axilla and groin (N, A, G), and asked to provide
an N and combined AG swab using a Copan E-swab
MRSA Collection System (Copan Diagnostics).
For participants in the MRSA-colonized arm taking
part in the follow-up component, written instructions
and links to instructional videos for the self-swabbing
procedure will be provided for future reference. Partici-
pants will be instructed to take two swabs, one from the
nares and a second from the axillary and groin areas,
and combine them in a single sample tube. Colour-
coded stickers will be pre-labelled with participants’
identification number and used to label the sample
tubes. Pre-paid, addressed, padded envelopes will be pro-
vided for participants to send the swabs directly to the
laboratory. Participants will submit swabs two and four
weeks after enrolment and at monthly intervals there-
after, at a pre-specified time of the month, for a period
of 6 months. Reminders will be sent by SMS. After
6 months, a second household visit will be arranged to
update information on healthcare contacts in the previ-
ous 6 months, recent travel history and contact patterns.
In a validation sub-study, the research team will take
swabs of the nares and axilla from a randomly selected
household member at the initial recruitment visit. The
selected household member will then take repeat swabs
by themselves, and take a third swab from the groin area
in a separate room. The five swab samples will be col-
lected in separate sample tubes, using the Copan E-swab
MRSA Collection System, and cultured individually to
validate the self-swabbing procedure to be used for
MRSA testing during the follow-up period.
Receipt of swab specimens will be recorded at the
laboratory located near hospital 1. A study team member
will liaise with the laboratory to ensure that specimens
have been received. Households from which samples
have not been received by the pre-specified date will be
contacted by the research nurse to ensure that samples
are taken and sent to the laboratory.
Sample size
Given an average household size of three persons, we
anticipate 200 household contacts in each arm. Lucet et
al. reported 88% participation among household con-
tacts16. Assuming 80% participation among household
contacts, a study with 160 participants in each arm, for a
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total sample size of 320, will enable us to detect a mini-
mum of 13% difference in MRSA prevalence between
the two groups. These estimates assume a Type I error
probability of 0.05, 80% power and a design effect
(DEFF) of 1.25 resulting from the clustered nature of the
survey design. We expect the design effect to be min-
imal, because of the small average number of partici-
pants recruited per household.
Laboratory procedures
All swabs will be tested for MRSA by culture on select-
ive chromogenic media (Bio-Rad MRSA Select™),
followed by a confirmatory agglutination test (Bio-Rad
Pastorex Staph Plus). If the first two tests are deemed in-
conclusive, a third coagulase test will be conducted.
Swab samples were plated onto selective chromogenic
media using sterile inoculating loops.The plates will be
incubated at 35-37 °C at ambient temperature and read
at 18–24 h. Negative plates or plates with minimal
growth will be re-incubated and re-read at 48 h. A latex
agglutination test will be performed on culture plates
with suspected MRSA colonies to confirm the presence
of Staphylococcus aureus.
Storage of MRSA isolates
Using a sterile loop, a mixture of different MRSA colonies
will be picked and emulsified in the cryopreservative fluid.
If culture growth is scarce, a subculture will be performed
and the colonies picked for storage in cryocare vials (Key
Scientific Products, Stamford, TX) at −80 °C.
Whole genome sequencing of MRSA isolates
The whole genome sequencing phase of the study will
require DNA to be extracted from the MRSA isolates.
The MRSA isolates from the hospital laboratory are re-
cultured on blood agar plates (BD Diagnostics, USA
BBL™ Columbia Agar with 5% sheep blood) from cryo-
care vials, and 5 individual colonies are picked per plate
for overnight culture in Luria-Bertani (LB) broth (Gibco®
LB Broth, Liquid). 900 μl from each overnight culture is
resuspended with 100 μl of sterile DMSO and stored as
independent MRSA isolates. The remaining DNA will be
extracted from these overnight cultures using the
QIAamp DNA Mini Kit (Qiagen Inc., Hilden, Germany).
Where multiple transmissions are suspected between
household members (for example, where a previously
negative household member is subsequently colonized),
a subset of strains from serial swabs will undergo whole
genome sequencing for molecular epidemiological stud-
ies. Genomic DNA will be extracted from S. aureus cul-
tures derived from swab samples of index patients and
household members. The isolates will be used to provide
background genetic information on the S. aureus strains
circulating locally. Genomic DNA will be extracted using
the QIAamp DNA Mini Kit (Qiagen Inc., Hilden,
Germany). DNA shearing will be done using Covaris
LE220 Focused-ultrasonicator followed by library prep-
aration using NEBNext® Ultra™ DNA Library Prep Kit
for Illumina® (E7370L) and custom primers with 8 bp
barcode index. Sequencing will be done on an Illumina
HiSeq 4 K platform.
Ethical approval
Ethical approval for this study has been obtained from
the National Health Group Domain Specific Review
Board (NHG-DSRB 2014/01278).
Data analysis
MRSA test results for duplicate swabs taken by trained
researchers, considered a “gold-standard test”, and par-
ticipants themselves from the same site will be used to
determine the sensitivity of self-swabbing. Sensitivity will
be defined as the proportion of positive nurse-
administered swabs for which the paired, self-
administered swab is also positive. Sensitivity will be cal-
culated for MRSA, and separately for nasal and axillary
swabs. Sensitivity estimates will be expressed as percent-
ages with corresponding 95% confidence intervals (CI).
Duration of MRSA carriage, by anatomical site, will be
quantified using survival analysis methods. Survival
curves will be plotted to show the changes in carriage
over time from serial samples. Survival curves will also
be used to investigate the incidence of colonization
among initially MRSA negative household contacts. The
longitudinal nature of data from serial samples will be
used to identify household and individual factors inde-
pendently associated to MRSA colonization and time to
MRSA clearance, using the Cox regression model. Asso-
ciations between time to clearance and independent risk
factors will be estimated by means of hazard ratios, with
corresponding 95% CIs. Robust methods will be used to
estimate standard errors, to account for dependence of
observations within households.
Data on chains of transmission with clonal strains
within households will enable estimation of household
reproduction numbers, i.e. the average number of colo-
nizations among household contacts arising from an
index patient, as well as enabling assessment of MRSA
colonization resulting from contact with sources other
than household contacts.
Phylogenetic analysis of isolated strains will enable
study of the genetic relatedness of MRSA strains associ-
ated with hospital encounters and MRSA strains circu-
lating in the community.
Discussion
As in many other countries, MRSA is endemic in
Singapore. Increased efforts at infection control in hospitals
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in recent years have contributed to a reported decline in
MRSA burden and subsequent stabilization of disease inci-
dence [30].
Studies of household contacts of MRSA index patients
have not been conducted in Singapore, and no longitu-
dinal studies in the community have been done in South-
east Asia. This project is novel since it will be the first to
conduct a longitudinal investigation of community trans-
mission of MRSA in Singapore. The study will help deter-
mine the direction of transmission and the MRSA
carriage dynamics over time. Understanding the dynamics
of MRSA persistence and transmission in the community
is crucial to devising and evaluating successful MRSA con-
trol strategies. Close contact with MRSA colonized pa-
tients may be important for MRSA persistence in the
community; evidence from this study on the extent of
community MRSA could inform the development of
household- or community-based interventions to reduce
MRSA colonization of close contacts and subsequent re-
introduction of MRSA into healthcare settings.
The study will use whole genome sequencing (WGS)
to delineate the molecular epidemiology of MRSA within
the healthcare system in Singapore. This will help to de-
termine whether these different types of institutions
share a common epidemiology dictated by the continu-
ing traffic of MRSA between institutions. MRSA isolates
from nasal, axillary and groin (NAG) swab cultures will
be typed by WGS and phylogenetic analysis used to es-
tablish the relationship between MRSA populations in
these different settings. Data from WGS provides super-
ior resolution and is less prone to false-positive and
false-negative findings [45]. WGS makes it possible to
achieve informative phylogenetic data which can provide
additional information about transmission events. Phylo-
genetic analysis of isolated strains will also enable the
study of the genetic relatedness of MRSA strains associ-
ated with hospital encounters and MRSA strains circu-
lating in the community.
Abbreviations
ACH: Acute Care Hospitals; CA-MRSA: Community-associated Methicillin-resistant
Staphylococcus aureus; CI: Confidence Interval; DEFF: Design Effect;
DNA: Deoxyribonucleic Acid; HA-MRSA: Healthcare-associated Methicillin-resistant
Staphylococcus aureus; MRSA: Methicillin-resistant Staphylococcus aureus;
NAG: Nasal, Axilla, Groin; NEB: New England Biolabs; NHG-DSRB: National Health
Group Domain Specific Review Board; PCR: Polymerase Chain Reaction;
ST: Sequence Type; WGS: Whole Genome Sequencing
Acknowledgments
Not applicable
Funding
This study is funded by a Communicable Diseases Public Health Research grant
from the Ministry of Health, Singapore (grant number: CDPHRG/0010/2014).
Availability of data and materials
Not applicable.
Authors’ contributions
NS, CCT and PFdS drafted the manuscript. All authors commented on and
approved the final manuscript.
Ethics approval and consent to participate
Interested patients will be asked to provide signed informed consent and
provide consent to contact their household for the purposes of recruiting
household members. For participants suffering from cognitive impairment,
informed consent will be obtained from their legally appointed
representative, usually a spouse or family member responsible for making
healthcare decisions on their behalf. For participants between the age of 6
and 12, assent will be obtained from the child and informed consent will be
obtained from their legally appointed representative, usually a parent or
guardian responsible for making decisions on their behalf.
Ethical approval for this study has been obtained from the National Health
Group Domain Specific Review Board (NHG-DSRB 2014/01278).
Consent for publication
All authors approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Saw Swee Hock School of Public Health, Tahir Foundation Building, 12
Science Drive 2, 11-01, Singapore 117549, Singapore. 2Tan Tock Seng
Hospital, Singapore, Singapore. 3National University Hospital, Singapore,
Singapore. 4Genome Institute of Singapore, Singapore, Singapore. 5London
School of Hygiene and Tropical Medicine, London, UK.
Received: 28 August 2017 Accepted: 4 October 2017
References
1. Baggett HC, Hennessy TW, Rudolph K, Bruden D, Reasonover A, Parkinson A, J.:
Community-onset methicillin-resistant Staphylococcus aureus associated with
antibiotic use and the cytotoxin Panton-Valentine leukocidin during a furunculosis
outbreak in rural Alaska. Dis 2004, 189 SRC - GoogleScholar:1565–1573.
2. Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK: Natural history of
community-acquired methicillin-resistant Staphylococcus aureus
colonization and infection in soldiers. Clin Infect Dis 2004, 39 SRC -
GoogleScholar:971–979.
3. Frazee BW, Lynn J, Charlebois ED, Lambert L, Lowery D, Perdreau-Remington F:
High prevalence of methicillin-resistant Staphylococcus aureus in emergency
department skin and soft tissue infections, vol 45; 2005.
4. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus
Aureus: epidemiology, underlying mechanisms, and associated risks. Clin
Microbiol Rev. 1997;10:505–20.
5. Nakashima AK, Allen JR, Martone WJ, Plikaytis BD, Stover B, Cook LN.
Epidemic bullous impetigo in a nursery due to a nasal carrier of
Staphylococcus Aureus: role of epidemiology and control measures. Infect
Control. 1984;5:326–31.
6. Solberg CO, J.: Spread of Staphylococcus aureus in hospitals: causes and
prevention. Scand Dis 2000, 32 SRC - GoogleScholar:587–595.
7. Vandenbergh MF, Verbrugh HA. J.: carriage of Staphylococcus Aureus:
epidemiology and clinical relevance. Clin Med. 1999;133:525–34.
8. Wang JT, Chang SC, Ko WJ, Chang YY, Chen ML, Pan HJ, J.: A hospital-
acquired outbreak of methicillin-resistant Staphylococcus aureus infection
initiated by a surgeon carrier. Infect 2001, 47 SRC - GoogleScholar:104–109.
9. Barnes SL, Harris AD, Golden BL, Wasil EA, Furuno JP. Contribution of
Interfacility patient movement to overall methicillin-resistant Staphylococcus
Aureus prevalence levels. Infect Control Hosp Epidemiol. 2011;32(11):1073–8.
10. Barr B, Wilcox MH, Brady A, Parnell P, Darby B, Tompkins D. Prevalence of
methicillin-resistant Staphylococcus Aureus colonization among older
residents of care homes in the United Kingdom. Infect Control Hosp
Epidemiol. 2007;28(7 SRC - GoogleScholar):853–9.
Shankar et al. BMC Infectious Diseases  (2017) 17:678 Page 5 of 6
11. Chow A, Lim VW, Khan A, Pettigrew K, Lye DCB. Mrsa: dynamics among
interconnected acute, intermediate-term, and long-term healthcare facilities
in Singapore. Clinical Infectious Diseases 64S2 2017:S76-81. SRC -
GoogleScholar.
12. Donker T, Wallinga J, Slack R, Grundmann H, LoS ONE: Hospital networks
and the dispersal of hospital-acquired pathogens by patient transfer. P
e35002 2012, 7(4 SRC - GoogleScholar).
13. Gamblin J, Jefferies JM, Harris S, Ahmad N, Marsh P, Faust SN, Fraser S,
Moore M, Roderick P, Blair I et al: Nasal self-swabbing for estimating the
prevalence of Staphylococcus aureus in the community. Microbiol 62Pt 3 7
2013:437–440. SRC - GoogleScholar.
14. Garazi M, Edwards B, Caccavale D, Auerbach C, Wolf-Klein G, J.: Nursing
homes as reservoirs of MRSA: myth or reality? Med Dir Assoc. 2009, 10 SRC -
GoogleScholar:414–418.
15. Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK,
Fosheim GE, Jensen BJ, Killgore G, Tenover FC, Kuehnert MJ, et al. Changes
in the prevalence of nasal colonization with Staphylococcus Aureus in the
United States. Dis ;:1226–34. 2008;197(9 SRC - GoogleScholar):2001–4.
16. Lee BY, Bartsch SM, Wong KF, Singh A, Avery TR, Kim DS, Brown ST, Murphy
CR, Yilmaz SL, Potter MA, et al. The importance of nursing homes in the
spread of methicillin-resistant Staphylococcus Aureus (MRSA) among
hospitals. Med Care van den The role of nursing homes in the spread of
antimicrobial resistance over the healthcare network Infect Control Hosp
Epidemiol 377617. 2016;51(3 SRC - GoogleScholar):205–15.
17. van den Dool C, Haenen A, Leenstra T, Wallinga J. The role of nursing
homes in the spread of antimicrobial resistance over the healthcare
network. Infect Control Hosp Epidemiol. 2016;37(7):761–7.
18. Johansson PJH, Gustafsson EB, Ringberg H: High prevalence of MRSA in
household contacts. Scandinavian Journal of Infectious Diseases 9
2007, 39 SRC - GoogleScholar:764–768.
19. Lautenbach E, Tolomeo P, Nachamkin I, Hu B, Zaoutis TE. The impact of
household transmission on duration of outpatient colonization with
methicillin-resistant Staphylococcus Aureus. Epidemiol Infect.
2010;138(5):638–85.
20. Lucet JC, Paoletti X, Demontpion C, Degrave M. D: Vanjak al Carriage of
MethicillinResistant Staphylococcus aureus in Home Care Settings Arch
Inern Med. 2009;169(15 SRC - GoogleScholar):1372–8.
21. Mollema FPN, Richardus JH, Behrendt M, Vaessen N, Lodder W: Transmission
of Methicillin-Resistant Staphylococcus aureus to Household Contacts.
Journal of Clinical Microbiology 1 2010, 48 SRC - GoogleScholar:202–207.
22. Ng W, Faheem A, McGeer A, Simor A, Gelosia A, Willey B, Risk T.
Community-and healthcare-associated methicillin-resistant Staphylococcus
Aureus strains: an investigation into household and environmental
contamination. Infection Control Hospital Epidemiology. 2016;38(01 SRC -
GoogleScholar):61–7.
23. Knox J, Rijen M, Uhlemann AC, Miller M, C.: Van Hafer al.
Communityassociated methicillinresistant Staphylococcus aureus
transmission in households of infected cases a pooled analysis of primary
data from three studies across international settings Epidemiol Infect 2015,
143 SRC - GoogleScholar:354–365.
24. Rafee Y, Abdel-Haq N, Asmar B, Salimnia T, Pharm CV, C. BM: Increased
prevalence of methicillin-resistant Staphylococcus aureus nasal colonization
in household contacts of children with community disease. Diseases 45
2012, 12 SRC - GoogleScholar.
25. Nerby JM, Gorwitz R, Lesher L, Juni B, Jawahir S: Risk Factors for Household
Transmission of Community-associated Methicillin-resistant Staphylococcus
aureus. The Pediatric Infectious Disease Journal 2011, 30 SRC -
GoogleScholar:927–932.
26. Hsu L, Tan T, Jureen R, Koh T, Krishnan P, Lin R. Antimicrobial drug
resistance in Singapore hospitals. Emerg Infect Dis. 2007;13(12):1944–7.
27. Hsu LY, Loomba-Chlebicka N, Koh YL, Tan TY, Krishnan P, Lin RT, Evolving E,
J.: 15 epidemic in Singapore hospitals. Microbiol 2007, 56 SRC -
GoogleScholar:376–379.
28. Hsu LY, Harris SR, Chlebowicz MA, Lindsay JA, Koh TH: Evolutionary
dynamics of methicillin-resistant Staphylococcus aureus within a healthcare
system. Genome Biology 81 2015, 16 SRC - GoogleScholar.
29. Hsu LY, Koh TH, Tan TY, Ito T, Ma XX, Med J: Emergence of community-
associated methicillin-resistant Staphylococcus aureus in Singapore: a
further six cases. Singapore 20 2006, 47(1 SRC - GoogleScholar).
30. Huang YC, Ho CF, Chen CJ, LH S, Lin TY. Nasal carriage of methicillin-
resistant Staphylococcus Aureus in household contact of children with
community-acquired diseases in Taiwan. Pediatr Infect Dis J.
2007;26(11):1066–8.
31. Fisher D, Tambyah PA, Lin RTP. J.: sustained methicillin-resistant
Staphylococcus Aureus control in a hyper-endemic tertiary acute care
hospital with infrastructure challenges in Singapore. Infection. 2013;85(2 SRC
- GoogleScholar):141–8.
32. Pereira LA, Fisher DA. Methicillin-resistant Staphylococcus Aureus control in
Singapore: moving forward. Ann Acad Med Singap. 2008;37(10):891–6.
33. Harrison EW, Ludden C, Brodrick HJ, Blane B, Brennan G: Transmission of
methicillin-resistant Staphylococcus aureus in long-term care facilities and
their related healthcare networks. Genome Med 102 2016, 8 SRC -
GoogleScholar.
34. Harris SR, Feil EJ, Holden MT, Quail MA, Nickerson EK, Chantratita N.
Evolution of MRSA during hospital transmission and intercontinental spread.
Science. 2010;327:469–74.
35. Parkhill J, Wren BW: Bacterial epidemiology and biology—lessons from
genome sequencing. Genome Biol 230 2011, 12 SRC - GoogleScholar.
36. Price JR, Golubchik T, Cole K. Whole-genome sequencing shows that
patient-to-patient transmission rarely accounts for acquisition of
Staphylococcus Aureus in an intensive care unit. Clin Infect Dis.
2014;58:609–18.
37. Tong SYC, Holden MTG, Nickerson EK, Cooper BS, Köser CU, Cori A, Jombart
T, Cauchemez S, Fraser C, Wuthiekanun V, et al. Genome sequencing
defines phylogeny and spread of methicillin-resistant Staphylococcus
Aureus in a high transmission setting. Genome Res. 2015;25(1):111–8.
38. Price JR, Gordon NC, Crook D, Llewelyn M, Paul J, Tong SY, Holden MT,
Nickerson EK: The usefulness of whole genome sequencing in the
management of Staphylococcus aureus infections. Clin Microbiol Infect
Genome sequencing defines phylogeny and spread of methicillinresistant
Staphylococcus aureus in a high transmission setting Genome Res 251118
2015, 19 SRC - GoogleScholar:784–789.
39. Kong Z, Zhao P, Liu H, Yu X, Qin Y, Su Z, LoS ONE: Whole-Genome
Sequencing for the Investigation of a Hospital Outbreak of MRSA in China.
P e0149844 2016, 11(3 SRC - GoogleScholar).
40. Pallen MJ, Loman NJ: Are diagnostic and public health bacteriology ready
to become branches of genomic medicine? Genome Med. 53 2011, 3
SRC - GoogleScholar.
41. Eyre DW, Golubchik T, Gordon NC, J. BM: A pilot study of rapid benchtop
sequencing of Staphylococcus aureus and Clostridium difficile for outbreak
detection and surveillance. e001124 2012, 2 SRC - GoogleScholar.
42. Alam MT, Read TD, Petit RA, M.: III, Transmission and microevolution of
USA300 MRSA in U. S households evidence from wholegenome sequencing
e00054 2015, 6 SRC - GoogleScholar.
43. Popovich KJ, Snitkin E, Green SJ, Aroutcheva A, Hayden MK, Hota B,
Weinstein RA. Genomic epidemiology of USA300 methicillin-resistant
Staphylococcus Aureus in an Urban Community. Clinical Infectious Diseases:
An Official Publication of the Infectious Diseases Society of America.
2016;62(1):37–44.
44. Uhlemann AC, Dordel J, Knox JR, Raven KE, Parkhill J. Molecular tracing of the
emergence, diversification and transmission of S aureus sequence type 8 in a
New York community PNAS. 2014;111(18 SRC - GoogleScholar):6738–43.
45. Salipante SJ, SenGupta DJ, Cummings LA, Land TA, Hoogestraat DR,
Cookson BT. Application of whole-genome sequencing for bacterial strain
typing in molecular epidemiology. J Clin Microbiol. 2015;53(4):1072–9.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Shankar et al. BMC Infectious Diseases  (2017) 17:678 Page 6 of 6
